Tumor inhibitors. 122. The maytansinoids. Isolation, structural elucidation, and chemical interrelation of novel ansa macrolides

Autor: S. M. Kupchan, H. P. J. Hintz, G. J. Thomas, William A. Court, G. A. Howie, Sumner Wc, Dailey Rg, Roger M. Smith, Albert T. Sneden, AR Branfman, A. Karim, V. A. Zimmerly, A. K. Verma, Yoshimitsu Nagao, Y. Komoda

Publikováno v: The Journal of Organic Chemistry. 42:2349-2357

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8bff2f8d5c2760319bbdc57014666ae2
https://doi.org/10.1021/jo00434a001

Advances in development of dopaminergic aporphinoids.

Autor: Zhang A; Synthetic Organic & Medicinal Chemistry Laboratory, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. aszhang@mail.shcnc.ac.cn, Zhang Y, Branfman AR, Baldessarini RJ, Neumeyer JL

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2007 Jan 25; Vol. 50 (2), pp. 171-81.

Quantitation of the antitumor agent N-(phosphonacetyl)-L-aspartic acid in human plasma and urine by gas chromatography-mass spectrometry-selected ion monitoring.

Autor: Branfman AR, Bruni RJ, Merrill YN, Chadwick M, Strong JM, Ervin TJ

Publikováno v: Journal of chromatography [J Chromatogr] 1980 May 09; Vol. 182 (2), pp. 163-9.

Comparative physiological disposition of N-(phosphonacetyl)-L-aspartate in several animal species after intravenous and oral administration.

Autor: Chadwick M, Silveira DM, MacGregor JA, Branfman AR, Liss RH, Yesair DW

Publikováno v: Cancer research [Cancer Res] 1982 Feb; Vol. 42 (2), pp. 627-32.

Structural requirements for antileukemic activity among the naturally occurring and semisynthetic maytansinoids.

Autor: Kupchan SM, Sneden AT, Branfman AR, Howie GA, Rebhun LI, McIvor WE, Wang RW, Schnaitman TC

Publikováno v: Journal of medicinal chemistry [J Med Chem] 1978 Jan; Vol. 21 (1), pp. 31-7.